You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR RISPERDAL CONSTA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for RISPERDAL CONSTA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00044655 ↗ Switching Medication to Treat Schizophrenia Completed National Institute of Mental Health (NIMH) Phase 4 2001-07-01 This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.
NCT00044655 ↗ Switching Medication to Treat Schizophrenia Completed Icahn School of Medicine at Mount Sinai Phase 4 2001-07-01 This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.
NCT00094926 ↗ A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes. Completed Janssen, LP Phase 3 2004-05-01 The purpose of this study is to examine the safety and effectiveness of the long acting injectable form of the atypical antipsychotic Risperidone (Risperdal CONSTA), along with treatment as usual (TAU), in bipolar disorder patients who had more than 4 mood episodes in the past year.
NCT00094926 ↗ A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes. Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 2004-05-01 The purpose of this study is to examine the safety and effectiveness of the long acting injectable form of the atypical antipsychotic Risperidone (Risperdal CONSTA), along with treatment as usual (TAU), in bipolar disorder patients who had more than 4 mood episodes in the past year.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for RISPERDAL CONSTA

Condition Name

Condition Name for RISPERDAL CONSTA
Intervention Trials
Schizophrenia 37
Schizoaffective Disorder 13
Psychotic Disorders 9
Bipolar Disorder 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for RISPERDAL CONSTA
Intervention Trials
Schizophrenia 37
Psychotic Disorders 22
Disease 14
Mental Disorders 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for RISPERDAL CONSTA

Trials by Country

Trials by Country for RISPERDAL CONSTA
Location Trials
United States 90
Canada 13
Malaysia 4
Ukraine 4
Poland 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for RISPERDAL CONSTA
Location Trials
California 11
Georgia 7
Texas 6
Florida 5
New York 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for RISPERDAL CONSTA

Clinical Trial Phase

Clinical Trial Phase for RISPERDAL CONSTA
Clinical Trial Phase Trials
Phase 4 21
Phase 3 15
Phase 2 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for RISPERDAL CONSTA
Clinical Trial Phase Trials
Completed 42
Terminated 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RISPERDAL CONSTA

Sponsor Name

Sponsor Name for RISPERDAL CONSTA
Sponsor Trials
Janssen, LP 10
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 10
National Institute of Mental Health (NIMH) 4
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for RISPERDAL CONSTA
Sponsor Trials
Industry 47
Other 17
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.